ZA200802544B - Association of BETA3 receptor agonist and monoamine reuptake inhibitors, pharmaceutical composition containing same and therapeutic use thereof - Google Patents

Association of BETA3 receptor agonist and monoamine reuptake inhibitors, pharmaceutical composition containing same and therapeutic use thereof

Info

Publication number
ZA200802544B
ZA200802544B ZA200802544A ZA200802544A ZA200802544B ZA 200802544 B ZA200802544 B ZA 200802544B ZA 200802544 A ZA200802544 A ZA 200802544A ZA 200802544 A ZA200802544 A ZA 200802544A ZA 200802544 B ZA200802544 B ZA 200802544B
Authority
ZA
South Africa
Prior art keywords
association
pharmaceutical composition
composition containing
receptor agonist
therapeutic use
Prior art date
Application number
ZA200802544A
Other languages
English (en)
Inventor
Griebel Guy
Stemmelin Jeanne
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ZA200802544B publication Critical patent/ZA200802544B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200802544A 2005-09-19 2006-09-18 Association of BETA3 receptor agonist and monoamine reuptake inhibitors, pharmaceutical composition containing same and therapeutic use thereof ZA200802544B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509528A FR2890862B1 (fr) 2005-09-19 2005-09-19 Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.

Publications (1)

Publication Number Publication Date
ZA200802544B true ZA200802544B (en) 2009-08-26

Family

ID=36384391

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200802544A ZA200802544B (en) 2005-09-19 2006-09-18 Association of BETA3 receptor agonist and monoamine reuptake inhibitors, pharmaceutical composition containing same and therapeutic use thereof

Country Status (23)

Country Link
US (1) US20080182899A1 (xx)
EP (1) EP1928448B1 (xx)
JP (1) JP2009508829A (xx)
KR (1) KR20080064115A (xx)
CN (1) CN101267814A (xx)
AR (1) AR055436A1 (xx)
AT (1) ATE441407T1 (xx)
AU (1) AU2006293801A1 (xx)
BR (1) BRPI0616197A2 (xx)
CA (1) CA2620235A1 (xx)
CR (1) CR9768A (xx)
DE (1) DE602006008964D1 (xx)
EA (1) EA200800870A1 (xx)
EC (1) ECSP088275A (xx)
FR (1) FR2890862B1 (xx)
IL (1) IL189755A0 (xx)
MA (1) MA30002B1 (xx)
NO (1) NO20081723L (xx)
NZ (1) NZ566310A (xx)
TN (1) TNSN08095A1 (xx)
TW (1) TW200744571A (xx)
WO (1) WO2007034056A1 (xx)
ZA (1) ZA200802544B (xx)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
US5288749A (en) * 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
US6288749B1 (en) * 1996-11-16 2001-09-11 Altec Lansing Technologies, Inc. Computer system with remote television display
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
RU2006107534A (ru) * 2003-09-12 2007-09-20 Уорнер-Ламберт Компани Ллс (Us) Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства

Also Published As

Publication number Publication date
NO20081723L (no) 2008-05-29
NZ566310A (en) 2010-03-26
MA30002B1 (fr) 2008-12-01
EA200800870A1 (ru) 2008-08-29
IL189755A0 (en) 2008-12-29
CA2620235A1 (fr) 2007-03-29
ATE441407T1 (de) 2009-09-15
EP1928448B1 (fr) 2009-09-02
FR2890862B1 (fr) 2008-01-25
AR055436A1 (es) 2007-08-22
DE602006008964D1 (de) 2009-10-15
TW200744571A (en) 2007-12-16
CN101267814A (zh) 2008-09-17
FR2890862A1 (fr) 2007-03-23
US20080182899A1 (en) 2008-07-31
AU2006293801A1 (en) 2007-03-29
JP2009508829A (ja) 2009-03-05
TNSN08095A1 (en) 2009-07-14
CR9768A (es) 2008-09-23
KR20080064115A (ko) 2008-07-08
ECSP088275A (es) 2008-04-28
WO2007034056A1 (fr) 2007-03-29
EP1928448A1 (fr) 2008-06-11
BRPI0616197A2 (pt) 2011-06-14

Similar Documents

Publication Publication Date Title
EP1942905A4 (en) NICOTINIC ACID RECEPTOR AGONISTS, COMPOSITIONS CONTAINING THESE COMPOUNDS, AND METHODS OF TREATMENT
EP1874301A4 (en) NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SAME, AND METHODS OF TREATMENT
IL188329A0 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
EP1765379A4 (en) CO-CRISTAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
IL191035A0 (en) Pharmaceutical use of substituted amides
IL195161A0 (en) Pharmaceutical compositions of ropinirole and methods of use thereof
EP1983993A4 (en) Niacin receptor agonists, compositions containing such compounds and method of treatment
EP1824812A4 (en) AGONISTS OF THE NIACIN RECEPTOR, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND TREATMENT PROCEDURES
EP2010512A4 (en) NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
EP1868985A4 (en) GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND METHODS OF USE
IL195071A (en) Antagonists / Agonists Cannabinoid Receptors and Medicines Containing Them
IL206562A0 (en) Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
EP2099450A4 (en) NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING THESE COMPOUNDS, AND METHODS OF TREATMENT
EP1971602A4 (en) AGONISTS OF THE NIACIN RECEPTOR, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND TREATMENT PROCEDURES
HK1144784A1 (en) Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands
EP1940402A4 (en) AGONISTS OF THE NIACIN RECEPTOR, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND TREATMENT PROCEDURES
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
IL209601A0 (en) Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders
EP2168584A4 (en) PHARMACEUTICAL COMPOSITION COMBINING TRIAZOLOBENZODIAZEPINE AND SELECTIVE SEROTONIN RECAPTURE SELECTIVE INHIBITOR
EP2233467A4 (en) ALPHA-AMINO N-SUBSTITUTED AMIDES, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USES THEREOF
IL198634A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL177750A0 (en) Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
ZA200802544B (en) Association of BETA3 receptor agonist and monoamine reuptake inhibitors, pharmaceutical composition containing same and therapeutic use thereof
EP2305633A4 (en) Novel Catechol Derivative, Pharmaceutical Composition Thereof, Use Of The Catechol Derivative And Use Of The Pharmaceutical Composition
IL188848A (en) A transient receptor antagonist (TRPVI) i, a pharmaceutical preparation containing it for the treatment of related diseases and conditions.